Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ALX Oncology

ALX Oncology?uq=U5Zpp9ZJ
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$23.1M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of protein-based therapeutics intended to help in cancer treatment. The company therapeutics with anticancer antibodies helps immune system to eradicate cancer from the system, enabling physicians to enhance the efficacy of antibody-based therapies in the clinical development.

Formerly Known As
Alexo Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 951 Gateway Boulevard
  • Suite 201
  • South San Francisco, CA 94080
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ALX Oncology’s full profile, request a free trial.

ALX Oncology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 01-Jan-2017 $23.1M 000.00 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ALX Oncology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Lightstone Ventures Venture Capital Minority 000 0000 000000 0
Stanford University Venture Fund Other Minority 000 0000 000000 0
The Longevity Fund Venture Capital Minority 000 0000 000000 0
venBio Venture Capital Minority 000 0000 000000 0
SPARK Scholars Accelerator/Incubator Minority 000 0000 000000 0

ALX Oncology Executive Team (8)

Name Title Board
Seat
Contact
Info
Jaume Pons Ph.D Chief Executive Officer, Board Member, President and Co-Founder
John Borgeson Chief Financial Officer
Hong Wan Ph.D Chief Scientific Officer
Nathan Caffo Chief Business Officer
Hank Stern Vice President, Chemistry, Manufacturing & Controls

1 Former Executive

You’re viewing 5 of 8 executives. Get the full list »

ALX Oncology Board Members (6)

Name Representing Role Since Contact
Info
Corey Goodman ALX Oncology Executive Chairman 000 0000
Jason Lettmann Lightstone Ventures Board Member 000 0000
Jaume Pons Ph.D ALX Oncology Chief Executive Officer, Board Member, President and Co-Founder 000 0000
K. Garcia ALX Oncology Board Observer & Board Member 000 0000
Laura Deming The Longevity Fund Board Observer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »